Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



More evidence for Pycnogenol endometriosis benefit

By Jess Halliday , 09-Mar-2007

A new study examining the potential of Pycnogenol to reduce endometriosis has yielded positive results, building the data to support the antioxidant pine extract's use in addressing the condition.

Pycnogenol, which is derived from the bark of maritime pine, which grows along the south west coast of France, already has a patent on its use to reduce pre-menstrual and menstrual pain. It has previously been studied for its ability to reduce abdominal pain due to endometriosis. The results of the new research build on this, and set up Pycnogenol as a potential side effect-free alternative to common hormone treatments used to address endometriosis. The condition, which affects a million women in the US alone, is when the tissue that lines the uterus grows on the outside instead of the inside. It is still shed each month, but is unable to leave the body, resulting in internal bleeding, inflammation and scar tissue. In extreme cases, a sufferer may become infertile or even require a hysterectomy. "Our results convey Pycnogenol as an extremely effective natural treatment without dangerous side effects," said lead researcher Takafumi Kohama. The study involved 58 women aged 21 to 38 years, who had all undergone operations for endometriosis in the six months before the study commenced. Regular menstruation and ovulation was confirmed during the three months prior to the study. Kohama and his team at the Kanazawa University School of Medicine in Ishokawa, Japan, randomly divided the women into two groups. One group received 30mg capsules of Pycnogenol twice a day, straight after morning and evening meals, for 48 weeks. The other group received 3.75mg injections of the goadotropin-releasing hormone agent (Gn-RHa) leuprorelin six times every four weeks, for 24 weeks. The women were examined at four, 12, 24 and 48 weeks to check for pain, urinary and bowel symptoms, and breakthrough bleeding. At he beginnings, neither course showed any differences and women in both groups reported severe pain, pelvic tenderness and pelvic indurations. After four weeks, Pycnogenols slowly reduced all symptoms from severe to moderate. The Gn-RHa treatment reduced the symptoms more efficiently, but a relapse was reported around the 24-week mark. What is more, Gn-Rha suppressed menstruation during treatment (an expected effect) and lowered oestrogen levels. Of the women taking Pycnogenol, however, five actually fell pregnant during the study. The earlier research on endometriosis-related abdominal pain, in which 80 per cent of the patients experienced a reduction of pain and 77 per cent disappearance of pain, was published in The European Bulletin of Drug Research. The new study is due to be published in an upcoming edition of the Journal of Reproductive Medicine, according to Natural Health Science, the North American distributor of Pycnogenol. The reference was not available at time of publication.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars